http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-47736-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4939fb2ee1623d7f34da940cdec13391 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate | 1978-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1984-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-47736-B1 |
| titleOfInvention | Improvements in or relating to a method of producing a vaccine for use in the immunotherapy of neoplastic disease |
| abstract | A process for producing a vaccine for use in the immunotherapy of neoplastic disease, said vaccine being produced by: (a) obtaining an amount of cancerous tissue from the patient to be treated and suspending said tissue in an aqueous solution of between about 100 and 150 millimolar sodium chloride and between about 5 and 15 millimolar sodium EDTA, (b) disaggregating the tissue into its component cells; (c) suspending the cells in water: (d) subjecting the suspended cells to hydrodynamic turbulence sufficient to disrupt the cells and detach therefrom the cell components possessing cancer-specific antigens; and (e) contacting and admixing the cell components obtained in step (d) with a source of manganousion to form the vaccine. [IN149012A1] |
| priorityDate | 1978-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.